AUSTIN, Texas, Feb. 21, 2012 \/PRNewswire\/ -- Celling Biosciences announces a sponsorship of the 7th Annual Stem Cell Summit being held on February 21st at Bridgewaters New York in New York City. The Stem Cell Summit is consistently the premiere venue for the world's leaders in regenerative medicine to network and promote next generation technologies and cell therapies. <\/p>\n
The meeting will feature more than 30 thought leaders in stem cell therapy including Dr. Kenneth Pettine of the Orthopedic Stem Cell Institute in Loveland, Colorado. Dr. Pettine has teamed up with Celling Biosciences' SpineSmith Division to present \"Adult Stem Cell Therapy for Orthopedic and Spine Conditions Resulting from Injury or Aging.\" Dr. Pettine has become an innovator in the regenerative cell therapy market and believes \"regenerative therapies will become the next standard of care in treating many orthopedic conditions.\" <\/p>\n
Following the Stem Cell Summit, Dr. Pettine will be presenting a discussion on regenerative therapies to the trainers and medical staff attending this year's NFL combine. The NFL has recently gained attention from Peyton Manning going oversees to receive a cell therapy treatment for his cervical spine condition. Dr. Pettine envisions a day when these professional athletes stop going to foreign countries to receive medical treatment. <\/p>\n
The Orthopedic Stem Cell Institute provides state-of-the-art regenerative cell therapy using Celling Biosciences' ART 21 system. The ART 21 system processes bone marrow from the patient at the point of care to consistently produce a concentrate of regenerative cells with high yields of mononuclear stem cells in less than 15 minutes. Celling Biosciences provides the cell separation systems along with the biomaterials and devices necessary to recreate the environment to promote healing. <\/p>\n
Kevin Dunworth, founder of Celling Biosciences, believes regenerative cell therapy has more to do with creating the optimal environment then just providing cells. \"We believe autologous cell therapy is a viable solution but physicians need to understand that these cells require the necessary substrate for delivery and the proper techniques for retrieval. Our focus has been on providing not only cell separation technologies, medical devices and biomaterials but also the registered nurses to deliver the service so physicians can have the most consistent, reliable and predictable regenerative cell therapy for their patients.\" <\/p>\n
Contact: About Celling Biosciences More here: AUSTIN, Texas, Feb. Continue reading
Tracy Gladden
Communications Manager
Tgladden@spinesmithusa.com<\/a>
512-637-2050 <\/p>\n
Celling Biosciences, works closely with surgeons, scientists and engineers to research and develop innovative technologies in the field of regenerative medicine. http:\/\/www.cellingbiosciences.com<\/a> and http:\/\/www.spinesmithusa.com<\/a> <\/p>\n<\/p>\n
\nCelling Biosciences Sponsors 7th Annual Stem Cell Summit<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"